https://www.selleckchem.com/pr....oducts/6-diazo-5-oxo
And applying these models to the cases the FDA designated, we proposed a new group categorization of combination products while focusing on the device component function. The new visualization models with PIU and PMOA and the new group categorization focusing on the device component function proposed in this study may increase predictability and acceptability of the classification of newly developed combination products into the regulatory scheme of drug, biological product, and device, for innovators, developers, and
Like
Comment
Share
